David Gattas gives an update on today's go-to anti-coagulant for renal replacement therapy.

David is an ANZICS CTG power player, with a growing list of publications and was involved in the RENAL and POST-RENAL studies.

This was recorded live at an ICN NSW / ANZICS meeting in September 2014.